U.S. Coronavirus Cases Increase at Slowest Pace in a Month

The video discusses the latest data on COVID-19 infections, highlighting a general flattening of the curve in the country, but with worsening situations in certain states like New Jersey and California. It also covers the excitement around Gilead's remdesivir treatment, with the FDA working quickly towards approval. Gilead plans to donate 1.5 million vials of the drug, while analysts question its revenue potential. The CEO emphasizes a balanced approach to providing the drug and maintaining company sustainability.

What trend is observed in the average growth rate of COVID-19 cases in the US?

• The growth rate is unpredictable.

• The growth rate remains constant.

• The growth rate is decreasing.

• The growth rate is increasing.

Which state reported a record one-day increase in COVID-19 deaths?

• California

• Florida

• Texas

• New Jersey

What is the FDA's approach to reviewing remdesivir data?

• They are taking a slow and cautious approach.

• They are not reviewing the data.

• They are working at lightning speed.

• They are waiting for more data.

How much is Gilead planning to spend on the new treatment?

• $500 million

• $1 billion

• $1.5 billion

• $2 billion

What is Gilead's CEO's stance on discussing remdesivir's revenue potential?

• He is eager to discuss it.

• He believes it is too early to discuss.

• He refuses to discuss it.

• He has already provided detailed revenue projections.